Although CTBP1 variants can lead to mitochondrial complex I and IV activities impairments in skeletal muscle, causing mitochondrial diseases (Sommerville et al., 2017), the patient we described did not exhibit any biochemical changes or muscle abnormalities. This evidence concerns the gene CTBP1 and mitochondrial disease.